Simplex Trading
AVDL

Simplex Trading’s Avadel Pharmaceuticals AVDL Stock Holding History

Simplex Trading’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-200
Closed -$310 – 9029
2025
Q4 		$310 Buy
+200
New +$3.88K ﹤0.01% 8219

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Simplex Trading's AVDL Position: Q4 2022 in Review

Simplex Trading sold out of Avadel Pharmaceuticals (AVDL) in Q4 2022, closing a stake of 2,100 shares — an estimated $10K sold.

Simplex Trading first reported a position in AVDL in Q4 2017 and held it in 3 quarters. The position peaked at $10K in Q3 2022. 83 funds tracked by Wall St. Rank hold AVDL as of Q4 2022.

  • Simplex Trading reported no remaining Avadel Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Simplex Trading sold 2,100 Avadel Pharmaceuticals shares in Q4 2022, an estimated $10K.
  • Simplex Trading first reported a position in Avadel Pharmaceuticals in Q4 2017 and held it in 3 quarters.
  • Simplex Trading's Avadel Pharmaceuticals position peaked at $10K in Q3 2022.
  • 83 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2022.

Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.